Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers.
Hosonaga M, Habano E, Arakawa H, Kaneko K, Nakajima T, Hayashi N, Fukada I, Nakamura A, Haruyama Y, Maeda T, Inari H, Kobayashi T, Nakashima E, Ueno T, Takano T, Takahashi S, Ohno S, Ueki A. Hosonaga M, et al. Among authors: inari h. Breast Cancer. 2024 Sep;31(5):988-996. doi: 10.1007/s12282-024-01612-3. Epub 2024 Jul 17. Breast Cancer. 2024. PMID: 39017822 Free PMC article.
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands.
Yoshida R, Kaneyasu T, Ueki A, Yamauchi H, Ohsumi S, Ohno S, Aoki D, Baba S, Kawano J, Matsumoto N, Nagasaki M, Ueno T, Inari H, Kobayashi Y, Takei J, Gotoh O, Nishi M, Okamura M, Kaneko K, Okawa M, Suzuki M, Amino S, Inuzuka M, Noda T, Mori S, Nakamura S. Yoshida R, et al. Among authors: inari h. Breast Cancer. 2024 Nov;31(6):1028-1036. doi: 10.1007/s12282-024-01615-0. Epub 2024 Jul 13. Breast Cancer. 2024. PMID: 39003386 Free PMC article.
Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.
Nomura H, Abe A, Fusegi A, Yoshimitsu T, Misaka S, Murakami A, Matsumoto T, Tsumura S, Kanno M, Aoki Y, Netsu S, Omi M, Tanigawa T, Okamoto S, Omatsu K, Yunokawa M, Kanao H, Habano E, Arakawa H, Kaneko K, Ueki A, Haruyama Y, Inari H, Ueno T. Nomura H, et al. Among authors: inari h. Sci Rep. 2023 Jan 19;13(1):1018. doi: 10.1038/s41598-023-28304-w. Sci Rep. 2023. PMID: 36658289 Free PMC article.
Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.
Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M. Inari H, et al. Breast Cancer. 2017 Nov;24(6):748-755. doi: 10.1007/s12282-017-0774-z. Epub 2017 Apr 19. Breast Cancer. 2017. PMID: 28425014
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Yamanaka A, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M. Inari H, et al. BMC Cancer. 2017 Feb 27;17(1):160. doi: 10.1186/s12885-017-3154-3. BMC Cancer. 2017. PMID: 28241804 Free PMC article.
15 results